Search Within

Alexander Noor Shoushtari

Formats
  1. Journal Article (112)
  2. Meeting Abstract (105)
  3. Research Letter (11)
  4. Editorial (7)
  5. Review (4)
  6. Book Section (3)
  7. Guidelines (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (244)
  2. Hematologic Malignancies, Division of (244)
  3. Melanoma Disease Management Team (244)
  4. Melanoma and Immunotherapeutics Service (244)
  5. Solid Tumor Oncology Division (244)
  6. GSK Faculty (86)

More Groups

People
  1. Michael Postow (63)
  2. Jedd Wolchok (49)
  3. Margaret Callahan (45)
  4. Paul Chapman (45)
  5. Katherine Panageas (34)
  6. Parisa Momtaz (32)

More People

Years
  1. 2025 (4)
  2. 2024 (22)
  3. 2023 (25)
  4. 2022 (38)
  5. 2021 (38)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (66)
  2. Annals of Oncology (22)
  3. Journal for ImmunoTherapy of Cancer (17)
  4. Clinical Cancer Research (11)
  5. Cancer Research (7)
  6. Melanoma Research (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (69)
  2. Oxford University Press (29)
  3. American Association for Cancer Research (21)
  4. Biomed Central Ltd (21)
  5. Nature Publishing Group (14)
  6. Elsevier Inc. (13)

More Publishers

Results (244)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characteristics and probability of survival for patients with advanced melanoma who live five or more years after initial treatment with immune checkpoint blockade (ICB)
    Meeting Abstract

    Loo, K.; Goldman, D. A.; Panageas, K.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Efficacy of checkpoint inhibitors (CPIs) in acral melanoma (AM)
    Meeting Abstract

    Bhave, P.; Ahmed, T.; Shoushtari, A.; Zaremba, A.; Versluis, J.; Mangana, J.; Weichenthal, M.; Si, L.; Lesimple, T.; Robert, C.; more...
    Asia-Pacific Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Association of plasma circulating tumor DNA with diagnosis of metastatic uveal melanoma
    Research Letter

    Francis, J. H.; Canestraro, J.; Brannon, A. R.; Barker, C. A.; Berger, M.; Shoushtari, A. N.; Abramson, D. H.
    JAMA Ophthalmology (2021)

    Fulltext@MSK | Save
  • A phase Ib study of sotrastaurin, a PKC inhibitor, and alpelisib, a PI3Kα inhibitor, in patients with metastatic uveal melanoma
    Journal Article

    Shoushtari, A. N.; Khan, S.; Komatsubara, K.; Feun, L.; Acquavella, N.; Singh-Kandah, S.; Negri, T.; Nesson, A.; Abbate, K.; Cremers, S.; more...
    Cancers (2021)

    Fulltext@MSK | Save
  • Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
    Journal Article

    Chapman, P. B.; Jayaprakasam, V. S.; Panageas, K. S.; Callahan, M.; Postow, M. A.; Shoushtari, A. N.; Wolchok, J. D.; Betof Warner, A.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Early use of high-dose glucocorticoid for the management of irAE is associated with poorer survival in patients with advanced melanoma treated with anti-PD-1 monotherapy
    Journal Article

    Bai, X.; Hu, J.; Betof Warner, A.; Quach, H. T.; Cann, C. G.; Zhang, M. Z.; Si, L.; Tang, B.; Cui, C.; Yang, X.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Early reduction in ctDNA, regardless of best RECIST response, is associated with overall survival (OS) on tebentafusp in previously treated metastatic uveal melanoma (mUM) patients
    Meeting Abstract

    Shoushtari, A. N.; Collins, L.; Espinosa, E.; Sethi, H.; Stanhope, S.; Abdullah, S.; Ikeguchi, A.; Ranade, K.; Hamid, O.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • A pilot study of engineered adenovirus ONCOS-102 in combination with pembrolizumab (pembro) in checkpoint inhibitor refractory advanced or unresectable melanoma
    Meeting Abstract

    Shoushtari, A. N.; Olszanski, A. J.; Nyakas, M.; Hornyak, T. J.; Wolchok, J. D.; Levitsky, V.; Møller, A. S.; Kuryk, L.; Handeland, K. R.; Jäderberg, M.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Efficacy of checkpoint inhibitors (CPIs) in acral melanoma (AM)
    Meeting Abstract

    Bhave, P.; Ahmed, T.; Shoushtari, A. N.; Zaremba, A.; Versluis, J. M.; Mangana, J.; Weichenthal, M.; Si, L.; Lesimple, T.; Robert, C.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Overall survival benefit with tebentafusp in metastatic uveal melanoma
    Journal Article

    Nathan, P.; Hassel, J. C.; Rutkowski, P.; Baurain, J. F.; Butler, M. O.; Schlaak, M.; Sullivan, R. J.; Ochsenreither, S.; Dummer, R.; Kirkwood, J. M.; more...
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save